Primary refractoriness to platelet transfusion caused by Naka antibody alone

被引:24
|
作者
Fujino, H
Ohta, K
Taniue, A
Nagao, N
Hino, M
Yamane, T
Koh, KR
Takeoka, Y
Hirose, A
Aoyama, Y
Nakamae, H
Terada, Y
Takubo, T
Tatsumi, N
机构
[1] Osaka City Univ, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan
[2] Osaka Red Cross Blood Ctr, Joto Ku, Osaka, Japan
关键词
Nak(a); platelet-specific antibodies; platelet transfusion; transfusion refractoriness;
D O I
10.1046/j.1423-0410.2001.00048.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives Anti-Nak(a), a platelet-specific antibody, occasionally causes platelet-transfusion refractoriness (PTR) together with human leucocyte antigen (HLA) antibodies. Anti-Naka usually appears after frequent platelet transfusions or pregnancy. We report the first case of PTR caused by anti-Nak(a) alone. Materials and Methods A 19-year-old male patient with testicular tumour showed PTR when receiving his first transfusion of platelets. Screening for platelet antigens and platelet antibodies revealed that he had type I CD36 (Nak(a)) deficiency and that anti-Nak(a), but not anti-HLA, was present before he received his first transfusion. Results The transfusion of Nak(a)-negative, but HLA non-selected, platelets was effective in raising the platelet count. Conclusion Clinically significant Nak(a) antibody was present as naturally occurring antibody in a platelet glycoprotein IV (CD36)-negative non-transfused male patient.
引用
收藏
页码:42 / 44
页数:3
相关论文
共 50 条
  • [32] The role of complement system in platelet transfusion refractoriness
    Savukoski, Susa
    Mannes, Marco
    Schultze, Anke
    Wohlgemuth, Lisa
    Huber-Lang, Markus
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 121 - 121
  • [33] PREVENTING REFRACTORINESS TO RANDOM DONOR PLATELET TRANSFUSION
    SNIECINSKI, I
    ODONNELL, M
    TRANSFUSION, 1986, 26 (06) : 582 - 582
  • [34] ABH ANTIBODIES CAUSING PLATELET TRANSFUSION REFRACTORINESS
    BRAND, A
    SINTNICOLAAS, K
    CLAAS, FHJ
    EERNISSE, JG
    TRANSFUSION, 1986, 26 (05) : 463 - 466
  • [35] Effects of Platelet Antibody Screen on Platelet Refractoriness Management
    Gross, M.
    Ygona, L.
    Gunn, A.
    Javier, L.
    Badjie, K.
    Thompson, T.
    Godbey, E.
    Christenson, C.
    TRANSFUSION, 2024, 64 : 279A - 280A
  • [36] Analysis of Platelet Antibodies and Acute Transfusion Reactions in Patients with Platelet Refractoriness
    Lin, J.
    Chen, Y.
    Lyou, J.
    Chiou, T.
    TRANSFUSION, 2011, 51 : 125A - 125A
  • [37] A NEW HYPOTHESIS CONCERNING THE MECHANISMS OF REFRACTORINESS TO PLATELET TRANSFUSION
    BLUMBERG, N
    HEAL, J
    MASEL, D
    TRANSFUSION, 1985, 25 (05) : 459 - 459
  • [38] HLA Alloimmunization is Not Always Predictive of Platelet Transfusion Refractoriness
    Crews, W. S.
    Kay, J. K.
    Herman, J. H.
    TRANSFUSION, 2013, 53 : 129A - 130A
  • [39] Can we "terminate" alloimmune platelet transfusion refractoriness?
    Vassallo, Ralph R.
    Norris, Philip J.
    TRANSFUSION, 2016, 56 (01) : 19 - 22